Navigation Links
Dilon Diagnostics Gamma-Guided Localization System Cleared by FDA
Date:12/21/2009

NEWPORT NEWS, Va., Dec. 21 /PRNewswire/ -- Dilon Diagnostics announced today that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for its lesion-localization system for molecular imaging biopsy guidance.

GammaLoc(®), pronounced "gamma-loke", is a complementary technology to Dilon's cornerstone product, the Dilon 6800(®) Gamma Camera. The GammaLoc(®) (GL) system will help doctors accurately locate breast lesions and enable gamma-guided biopsies, particularly useful for patients that have findings on the Dilon system that are not revealed with other imaging modalities.

The GammaLoc(® )system utilizes a CorreLocator(TM) paddle and a StereoView(TM) imaging collimator system - a technique similar to that used in stereotactic X-ray localization, and the GammaLoc(®) software calculates the specific location of the suspect lesion. The compact design allows for breast biopsies with optimal patient comfort; and the entire system is small and portable, allowing physicians to perform molecular imaging guided biopsy procedures anywhere on site.

"Thanks to the superior performance of the Dilon 6800 camera combined with this new biopsy-guidance capability, physicians will find it easier to locate suspicious lesions seen with molecular breast imaging, greatly facilitating and expediting the biopsy process," said Robert Moussa, President and CEO of Dilon Diagnostics. "This recent innovation helps physicians improve patient management and confidently deliver faster, more accurate results to their anxious patients."

About Dilon Diagnostics

Dilon Diagnostics, a brand of Dilon Technologies Inc. is bringing innovative new medical imaging products to market. Dilon's cornerstone product, the Dilon 6800, is a high-resolution, small field-of-view gamma camera, optimized to perform BSGI, a molecular breast imaging procedure which images the metabolic activity of breast lesions through radiotracer uptake. Many leading medical centers around the country are now offering BSGI to their patients, including: Cornell University Medical Center, New York; George Washington University Medical Center, Washington, D.C.; and The Rose, Houston. For more information on Dilon Technologies please visit www.dilon.com.

SOURCE Dilon Diagnostics


'/>"/>
SOURCE Dilon Diagnostics
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Dilon Diagnostics Gamma-Guided Localization System Cleared by FDA
2. Dilon Technologies Leads Molecular Breast Imaging Expansion
3. Dilon Technologies Slant15(TM) and LEHR Collimators Enhance Imaging Capabilities
4. Dilon Technologies Signs Amerinet for Breast-Specific Gamma Imaging
5. Dilon Technologies Announces National Agreement with MedAssets
6. Settlement Reached Between Dilon Technologies and Naviscan on Patent Rights
7. Dilon Technologies Appoints New VP of Sales & Business Development
8. Dilon Technologies Explores Improvements in Molecular Breast Imaging
9. End of H1N1 Second Wave in Sight in the U.S., According to Quest Diagnostics
10. Arrayit Diagnostics to Bring First Pre-Symptomatic Ovarian Cancer Blood Test to Multi-Billion Dollar Diagnostic Market in 2010
11. PLUS Diagnostics Launches Hematology/Oncology Diagnostic Services
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... ... December 08, 2016 , ... Today’s patients are ... this in mind, SIGVARIS has created a new line of anti-embolism stockings to ... and provide the benefits of graduated compression when transitioning from recovery to early ...
(Date:12/8/2016)... ... , ... Vida Health, the digital health platform that pairs individuals ... Ventures . Other investors include Nokia Growth Partners (NGP) and returning investor Aspect Ventures. ... who are managing chronic conditions or simply want to improve their health. ...
(Date:12/8/2016)... ... December 08, 2016 , ... The ... from offices headquartered in Hamilton County, is embarking on a charity drive with ... in finding new homes for orphaned or neglected senior dogs in the Cincinnati ...
(Date:12/8/2016)... ... December 08, 2016 , ... Peter Zipp ... in and around the greater Phoenix metropolitan region, is announcing a charity event ... mission of the Homeless Youth Connection is to promote community awareness of the ...
(Date:12/8/2016)... ... December 08, 2016 , ... The Compretta Insurance Agency, a family owned insurance ... around the Hancock County area, is announcing the launch of a charity effort aimed ... Hancock County Food Pantry has worked for more than 30 years to meet the ...
Breaking Medicine News(10 mins):
(Date:12/9/2016)... Japan , Dec. 9, 2016 Mitsubishi ... ; President & Representative Director, CEO: Dr. Masayuki ... amyotrophic lateral sclerosis (ALS) given edaravone intravenously in 10-14 ... loss as measured by the ALS Functional Rating Scale-Revised ... International Symposium on ALS/MND in Dublin, ...
(Date:12/9/2016)... Research and Markets has announced the addition of the ... ... travel vaccines market to grow at a CAGR of 6.83% during ... and the growth prospects of the global travel vaccines market for ... generated from the sales of various vaccines administered to actively immunize ...
(Date:12/9/2016)... DIEGO , Dec. 9, 2016  Forge ... Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX, ISIN: ... targeting ,LpxC, for the treatment of bacterial infections ... has been recognized as an attractive antibacterial target ... a lack of suitable chemical starting points has ...
Breaking Medicine Technology: